Zhenzhen Liu, Ph.D.
Affiliations: | 2012 | Biochemistry | Ohio State University, Columbus, Columbus, OH |
Area:
Biochemistry, ImmunologyGoogle:
"Zhenzhen Liu"Mean distance: (not calculated yet)
Parents
Sign in to add mentorLai-Chu Wu | grad student | 2012 | Ohio State | |
(The Roles of Interleukin-27 in Tumor Immunity.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Yu XJ, Yang MJ, Zhou B, et al. (2015) Characterization of Somatic Mutations in Air Pollution-Related Lung Cancer. Ebiomedicine. 2: 583-590 |
Liu Z, Liu JQ, Shi Y, et al. (2015) Epstein-Barr virus-induced gene 3-deficiency leads to impaired antitumor T-cell responses and accelerated tumor growth. Oncoimmunology. 4: e989137 |
Wang L, Liu JQ, Talebian F, et al. (2015) IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4(+) T cells and promoting CTL persistence in a murine model of plasmacytoma. Oncoimmunology. 4: e1014232 |
Li MS, Liu Z, Liu JQ, et al. (2015) The Yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy. Immunotherapy. 7: 191-200 |
Wu LC, Chiang CJ, Liu ZH, et al. (2014) Fabrication and properties of acellular porcine anulus fibrosus for tissue engineering in spine surgery. Journal of Orthopaedic Surgery and Research. 9: 118 |
Young NA, Bruss MS, Gardner M, et al. (2014) Oral administration of nano-emulsion curcumin in mice suppresses inflammatory-induced NFκB signaling and macrophage migration. Plos One. 9: e111559 |
Wu LC, Wen ZS, Qiu YT, et al. (2013) Largazole Arrests Cell Cycle at G1 Phase and Triggers Proteasomal Degradation of E2F1 in Lung Cancer Cells. Acs Medicinal Chemistry Letters. 4: 921-6 |
Yu J, Peng Y, Wu LC, et al. (2013) Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia. Plos One. 8: e55934 |
Wang Z, Liu JQ, Liu Z, et al. (2013) Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis. Journal of Immunology (Baltimore, Md. : 1950). 190: 2415-23 |
Liu Z, Liu JQ, Talebian F, et al. (2013) IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells. European Journal of Immunology. 43: 468-79 |